• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Moderna, PayPal And Some Other Big Gainers From Wednesday

    8/4/22 4:00:00 AM ET
    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Transportation Services
    Consumer Discretionary
    Finance: Consumer Services
    Finance
    Get the next $AAWW alert in real time by email

    U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.

    • Ping Identity Holding Corp. (NYSE:PING) shares jumped 60.7% to close at $28.08 after the company announced it will be acquired by Thoma Bravo for $28.50 per share in cash. Ping Identity also posted a Q2 loss of $0.34 per share.
    • Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) surged 49.3% to settle at $212.01 after the company announced the results from its APOLLO-B Phase 3 study of patisiran met the primary endpoint and also met the first secondary endpoint.
    • Tupperware Brands Corporation (NYSE:TUP) surged 32.4% to close at $9.53 after the company reported better-than-expected Q2 results.
    • SoFi Technologies, Inc. (NASDAQ:SOFI) climbed 28.4% to close at $8.23 after the company reported better-than-expected Q2 results and raised FY22 guidance.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 23.7% to settle at $17.53. Morgan Stanley maintained Rhythm Pharmaceuticals with an Equal-Weight and raised the price target from $8 to $16.
    • Coinbase Global, Inc. (NASDAQ:COIN) jumped 20.2% to close at $80.81.
    • Clearwater Paper Corporation (NYSE:CLW) gained 19.3% to close at $41.51 following strong quarterly sales.
    • Alteryx, Inc. (NYSE:AYX) climbed 19% to close at $60.20 following strong Q2 results.
    • Moderna, Inc. (NASDAQ:MRNA) jumped 16% to close at $186.49 after the company reported better-than-expected Q2 EPS and sales results and announced a $3 billion buyback.
    • Globalstar, Inc. (NASDAQ:GSAT) rose 15% to settle at $1.61.
    • Unum Group (NYSE:UNM) gained 14.6% to settle at $35.93 after the company reported better-than-expected Q2 EPS and sales results.
    • Upstart Holdings, Inc. (NASDAQ:UPST) gained 14.2% to close at $29.06.
    • Herbalife Nutrition Ltd. (NYSE:HLF) jumped 13.6% to close at $27.50 following Q2 results.
    • Sprout Social, Inc. (NASDAQ:SPT) gained 13.3% to settle at $58.91 after the company reported better-than-expected Q2 EPS and sales results.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 13.3% to close at $31.89 amid strength in the broader payments space following strong quarterly results from PayPal.
    • MicroStrategy Incorporated (NASDAQ:MSTR) surged 12.7% to settle at $313.68 after the company reported Q2 results and announced a CEO change.
    • Camping World Holdings, Inc. (NYSE:CWH) gained 12.5% to close at $29.84 after the company reported better-than-expected Q2 EPS and sales results.
    • PagSeguro Digital Ltd. (NYSE:PAGS) surged 12.4% to close at $12.23.
    • Wayfair Inc. (NYSE:W) gained 12.2% to settle at $64.44.
    • Asana, Inc. (NYSE:ASAN) surged 12.2% to close at $23.14.
    • Autohome Inc. (NYSE:ATHM) rose 11.7% to settle at $39.74 after the company reported better-than-expected Q2 sales results.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) jumped 11.7% to settle at $10.31 after the company reported better-than-expected Q2 EPS results.
    • Block, Inc. (NYSE:SQ) rose 11.4% to close at $88.07 ahead of quarterly earnings, scheduled for release today.
    • Shopify Inc. (NYSE:SHOP) rose 11.1% to close at $41.93.
    • Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) gained 10.8% to close at $96.78 following a Monday Wall Street Journal report suggesting Apollo Global Management was in advanced talks to acquire the company. Additionally, Wolfe Research upgraded the stock from Underperform to Peer Perform.
    • Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) rose 10.3% to close at $41.02. Ionis Pharmaceuticals recently announced positive topline results of the Phase 2b clinical trial of fesomersen in patients with end-stage renal disease (ESRD) on hemodialysis.
    • Unity Software Inc. (NYSE:U) surged 10% to close at $45.06 following Tuesday reports suggesting the company will spin off its China unit.
    • Coupa Software Incorporated (NASDAQ:COUP) gained 9.9% to close at $75.36.
    • PayPal Holdings, Inc. (NASDAQ:PYPL) rose 9.3% to close at $97.92 after the company reported better-than-expected Q2 results and raised FY22 EPS guidance.
    • Paymentus Holdings, Inc. (NYSE:PAY) jumped 9% to settle at $18.11 following Q2 results.
    Get the next $AAWW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAWW
    $AFRM
    $ALNY
    $ASAN

    CompanyDatePrice TargetRatingAnalyst
    Upstart Holdings Inc.
    $UPST
    2/13/2026$20.00Mkt Perform → Mkt Underperform
    Citizens
    Upstart Holdings Inc.
    $UPST
    2/13/2026$35.00Sell → Neutral
    Goldman
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Robinhood Markets Inc.
    $HOOD
    2/11/2026$135.00 → $100.00Buy
    Needham
    Shopify Inc.
    $SHOP
    2/10/2026$150.00Neutral → Buy
    MoffettNathanson
    PayPal Holdings Inc.
    $PYPL
    2/10/2026$58.00 → $39.00Sell
    Truist
    More analyst ratings

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Lavet Robert S bought $105,220 worth of shares (5,000 units at $21.04) (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/6/26 6:18:51 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    EVP GBUL Borrow Schuppenhauer Eric bought $99,650 worth of shares (5,000 units at $19.93), increasing direct ownership by 2% to 228,768 units (SEC Form 4)

    4 - SoFi Technologies, Inc. (0001818874) (Issuer)

    2/5/26 5:53:28 PM ET
    $SOFI
    Finance: Consumer Services
    Finance

    CEO Barretto Ryan Paul bought $1,002,621 worth of shares (93,984 units at $10.67), increasing direct ownership by 12% to 875,256 units (SEC Form 4)

    4 - Sprout Social, Inc. (0001517375) (Issuer)

    1/13/26 4:01:19 PM ET
    $SPT
    Computer Software: Prepackaged Software
    Technology

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: EVP, Chief Scientific Officer Bennett C Frank disposed of 0 shares (SEC Form 4)

    4/A - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:36 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP Research Swayze Eric sold $1,278,914 worth of shares (15,642 units at $81.76), decreasing direct ownership by 33% to 32,105 units (SEC Form 4)

    4 - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:24 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Parshall B Lynne sold $413,588 worth of shares (5,000 units at $82.72), decreasing direct ownership by 8% to 56,344 units (SEC Form 4)

    4 - IONIS PHARMACEUTICALS INC (0000874015) (Issuer)

    2/13/26 7:40:10 PM ET
    $IONS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Paymentus Holdings Inc.

    SCHEDULE 13G/A - Paymentus Holdings, Inc. (0001841156) (Subject)

    2/13/26 6:27:22 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Paymentus Holdings Inc.

    SCHEDULE 13G/A - Paymentus Holdings, Inc. (0001841156) (Subject)

    2/13/26 5:32:39 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Upstart Holdings Inc.

    SCHEDULE 13G/A - Upstart Holdings, Inc. (0001647639) (Subject)

    2/13/26 5:23:16 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXLUMO issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug OXLUMO (SUPPL-4) with active ingredient LUMASIRAN SODIUM has changed to 'Approval' on 09/19/2023. Application Category: NDA, Application Number: 214103, Application Classification: Labeling

    9/20/23 2:36:38 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for AMVUTTRA issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug AMVUTTRA (SUPPL-2) with active ingredient VUTRISIRAN has changed to 'Approval' on 02/16/2023. Application Category: NDA, Application Number: 215515, Application Classification: Labeling

    2/17/23 12:30:09 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Upstart downgraded by Citizens with a new price target

    Citizens downgraded Upstart from Mkt Perform to Mkt Underperform and set a new price target of $20.00

    2/13/26 8:31:11 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Upstart upgraded by Goldman with a new price target

    Goldman upgraded Upstart from Sell to Neutral and set a new price target of $35.00

    2/13/26 8:26:40 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Coinbase Global downgraded by Monness Crespi & Hardt with a new price target

    Monness Crespi & Hardt downgraded Coinbase Global from Buy to Neutral and set a new price target of $120.00

    2/12/26 7:44:13 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Coinbase Delivers on Q4 Financial Outlook, Doubles Total Trading Volume and Crypto Trading Volume Market Share in 2025

    All-time high Coinbase Total Trading Volume, up 156% Y/Y, outperforming the market All-time high Coinbase Crypto Trading Volume Market Share up 103% Y/Y All-time high Subscription and Services Revenue in 2025 All-time high Paid Coinbase One Subscribers in 2025, up 3x in 3 years Coinbase Global, Inc. (NASDAQ:COIN) has posted a shareholder letter containing its financial results for the fourth quarter and full year ended December 31, 2025 on its Investor Relations website at investor.coinbase.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212063960/en/ All Q4 financial results were within expected ranges, reflectin

    2/12/26 4:09:00 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Sabre, PayPal, and Mindtrip partner to deliver the industry's first end-to-end agentic AI experience for travel

    An unprecedented collaboration combines AI, trusted identity, payments, and enterprise travel infrastructure to create personalized experiences and usher the travel ecosystem into the next era. SOUTHLAKE, Texas and SAN JOSE, Calif. and PALO ALTO, Calif., Feb. 12, 2026 /PRNewswire/ --  Sabre Corporation (NASDAQ:SABR),  PayPal Holdings (NASDAQ:PYPL), and Mindtrip, today announced a strategic partnership to deliver a next-generation agentic AI experience that reimagines how consumers discover, plan, book, and manage travel. The collaboration unites Mindtrip's agentic consumer platform, PayPal's agentic commerce capabilities, and Sabre's unparalleled enterprise-grade travel technology and agenti

    2/12/26 9:00:00 AM ET
    $PYPL
    $SABR
    Diversified Commercial Services
    Industrials
    Computer Software: Programming Data Processing
    Technology

    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress

    − Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared to Same Periods in 2024 – − Attained GAAP and non-GAAP Profitability for Full Year 2025, with Sustainable Growth in Operating Income Expected – − Launched "Alnylam 2030" Strategy Focused on Scaling Alnylam through Durable ATTR Leadership, Long-Term Sustainable Innovation, and Exceptional Financial Results – − Announced 2026 Pipeline Goals, Including 4 Clinical Readouts, 3 Ongoing Pivotal Studies, 3 Phase 2 Study Initiations, and 3+ New IND Filings – − Reiterates Net Product Sales Guidance and Provides Additional 2026 Fin

    2/12/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Leadership Updates

    Live Leadership Updates

    View All

    Unity Appoints Bernard Kim to its Board of Directors and Announces Board Transitions

    Unity (NYSE:U), the world's leading game engine, today announced the appointment of gaming and technology veteran Bernard Kim as an independent director to its Board of Directors, effective May 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210709281/en/Bernard Kim "Bernard brings deep experience building and scaling global, public companies at the intersection of games and technology," said Jim Whitehurst, Chairman of Unity's Board of Directors. "His leadership across mobile gaming, advertising technology, and consumer platforms will be a valuable addition to the Unity Board." "Unity plays a foundational role in h

    2/10/26 4:15:00 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    PayPal Appoints Enrique Lores as Chief Executive Officer and David W. Dorman as Independent Board Chair

    SAN JOSE, Calif., Feb. 3, 2026 /PRNewswire/ -- PayPal Holdings Inc. (NASDAQ:PYPL) today announced that its Board of Directors has appointed Enrique Lores as President and CEO, effective March 1, 2026. Lores, who has served on the PayPal Board for nearly five years and as Board Chair since July 2024, succeeds Alex Chriss. To ensure a seamless transition, Jamie Miller, Chief Financial and Operating Officer, will serve as Interim CEO until Lores assumes the role. David W. Dorman has been appointed as Independent Board Chair, effective immediately. Today's appointment follows a de

    2/3/26 6:58:00 AM ET
    $PYPL
    Diversified Commercial Services
    Industrials

    PayPal to Acquire Cymbio, Accelerating Agentic Commerce Capabilities

    Cymbio will enable tens of millions of merchants to become discoverable on leading AI platforms SAN JOSE, Calif., Jan. 22, 2026 /PRNewswire/ -- PayPal Holdings, Inc. (NASDAQ:PYPL) today announced it has agreed to acquire Cymbio, a multi-channel orchestration platform that helps brands sell across agentic surfaces, including Microsoft Copilot and Perplexity, and other e-commerce channels. PayPal previously partnered with Cymbio as part of its agentic commerce services, a suite of solutions that allows merchants to attract customers and drive sales in the new era of AI-powered commerce.  "PayPal has established itself as a leading commerce partner for merchants looking to sell within top AI p

    1/22/26 7:15:00 AM ET
    $PYPL
    Diversified Commercial Services
    Industrials

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Financials

    Live finance-specific insights

    View All

    Coinbase Delivers on Q4 Financial Outlook, Doubles Total Trading Volume and Crypto Trading Volume Market Share in 2025

    All-time high Coinbase Total Trading Volume, up 156% Y/Y, outperforming the market All-time high Coinbase Crypto Trading Volume Market Share up 103% Y/Y All-time high Subscription and Services Revenue in 2025 All-time high Paid Coinbase One Subscribers in 2025, up 3x in 3 years Coinbase Global, Inc. (NASDAQ:COIN) has posted a shareholder letter containing its financial results for the fourth quarter and full year ended December 31, 2025 on its Investor Relations website at investor.coinbase.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212063960/en/ All Q4 financial results were within expected ranges, reflectin

    2/12/26 4:09:00 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress

    − Achieved Fourth Quarter and Full Year 2025 Global Net Product Revenues of $995 Million and $2,987 Million, Respectively, Representing 121% and 81% Growth Compared to Same Periods in 2024 – − Attained GAAP and non-GAAP Profitability for Full Year 2025, with Sustainable Growth in Operating Income Expected – − Launched "Alnylam 2030" Strategy Focused on Scaling Alnylam through Durable ATTR Leadership, Long-Term Sustainable Innovation, and Exceptional Financial Results – − Announced 2026 Pipeline Goals, Including 4 Clinical Readouts, 3 Ongoing Pivotal Studies, 3 Phase 2 Study Initiations, and 3+ New IND Filings – − Reiterates Net Product Sales Guidance and Provides Additional 2026 Fin

    2/12/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Autohome Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026

    BEIJING, Feb. 12, 2026 /PRNewswire/ -- Autohome Inc. (NYSE:ATHM, HKEX: 2518)) ("Autohome" or the "Company"), a leading online destination for automobile consumers in China, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before U.S. markets open on March 5, 2026. Autohome's management team will host an earnings conference call at 7:00 AM U.S. Eastern Time on Thursday, March 5, 2026 (8:00 PM Beijing Time on the same day). Please register in advance of the conference using the registration link provided below. Upon registering, each participant will receive a set of participant dial-in numbers and a personal PIN, which wi

    2/12/26 4:30:00 AM ET
    $ATHM
    EDP Services
    Technology

    $AAWW
    $AFRM
    $ALNY
    $ASAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Camping World Holdings Inc.

    SC 13G/A - Camping World Holdings, Inc. (0001669779) (Subject)

    11/15/24 6:03:40 AM ET
    $CWH
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Rhythm Pharmaceuticals Inc.

    SC 13G - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Subject)

    11/14/24 9:50:26 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care